Antigua and Barbuda vs Mongolia: Prevalence rate of diabetes in adults
Antigua and Barbuda
11.5
in 2014
Mongolia
11.7
in 2014
Antigua and Barbuda rank
48th
Mongolia rank
46th
Prevalence rate of diabetes in adults over time
- Antigua and Barbuda
- Mongolia
How they compare
Mongolia currently reports 11.7 against 11.5 in Antigua and Barbuda, a difference of 0.2.
Across all 35 years both countries report, Mongolia has been ahead every year.
Antigua and Barbuda ranks 48th and Mongolia ranks 46th of 190 countries.
Mongolia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 5.29 | 5.81 | 0.52 | Mongolia |
| 1990s | 6.72 | 7.2 | 0.48 | Mongolia |
| 2000s | 8.76 | 9 | 0.24 | Mongolia |
| 2010s | 10.84 | 11.02 | 0.18 | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of diabetes in adults, Antigua and Barbuda or Mongolia?
- Mongolia, at 11.7 against 11.5 in Antigua and Barbuda as of 2014.
- What is the difference in prevalence rate of diabetes in adults between Antigua and Barbuda and Mongolia?
- 0.2, with Mongolia ahead.
- How many years of comparable data are there for Antigua and Barbuda and Mongolia?
- 35 years are reported by both, from 1980 to 2014.
- How do Antigua and Barbuda and Mongolia rank globally for prevalence rate of diabetes in adults?
- Antigua and Barbuda ranks 48th and Mongolia ranks 46th of 190 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of diabetes in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of people with diabetes among those aged over 18, based on general population surveys and statistical modeling. Diabetes is a risk factor for chronic complications, including cardiovascular disease, and premature death.